CLRB (Cellectar Biosciences) Wutah bathi resik saben saham ing taun iki

CLRB (Cellectar Corp) - tandha merek perusahaan

Cellectar Biosciences (CLRB) is effectively scaling drug production through proven CMO networks. Annual EPS variability demonstrates the impact of a diversified radiopharmaceutical portfolio on reducing capital risks. Meanwhile, the 71.60 mark serves as a current indicator that accounts for the complexities of ultra-fast isotope logistics. This earnings per share trend confirms the company's fundamental resilience to market volatility.

Wutah bathi saben saham ing taun lumaku: Cellectar Biosciences Inc (CLRB) kanggo 04.07.2022 - 12.11.2026

Rincian metrik keuangan lan pasar Cellectar Biosciences (CLRB)

- kuotasi lan prakiraan analis:
Kurs saham Cellectar Biosciences Inc|CLRB - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Biji pasar Cellectar Corp|CLRB - Nilai Total Perusahaan
- rincian nilai buku perusahaan:
Nilai Aset Bersih saben Saham Cellectar Biosciences|CLRB - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku cellectar.com|CLRB - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal Cellectar Biosciences|CLRB - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas cellectar.com|CLRB - Gunggung utang perusahaan|Utang-utang marang nilai buku Cellectar Corp|CLRB - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Cellectar Biosciences|Rasio likuiditas perantara cellectar.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
CLRB - Bathi resik|Penghasilan resik sing dikarepake Cellectar Biosciences|CLRB - Pangali P/E|Rasio prakiraan rega marang bathi Cellectar Corp|CLRB - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Cellectar Corp|CLRB - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Cellectar Biosciences|CLRB - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan cellectar.com|CLRB - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham ing taun ngarep Cellectar Biosciences
Ringkesan analisis perusahaan:CLRB Cellectar Biosciences Inc
Produk mawa merek Cellectar Biosciences

A conservative approach requires a thorough analysis of earnings per share dynamics. For Cellectar Biosciences (CLRB), which focuses on radiopharmaceutical development, this criterion confirms the effectiveness of investments in clinical trials. By analyzing annual EPS fluctuations, an investor can see the percentage deviation of current net income from the previous year's figures. Growth in this metric signals the capitalization of innovations. A steady increase in this value determines the long-term investment attractiveness of the asset.

Pesaing wigati

Wutah bathi saben saham ing taun iki INCY|HCM (HUTCHMED Ltd) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Nuvation Corp (NUVB)|Wutah bathi saben saham ing taun lumaku Day One (DAWN)|MNPR - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Inhibrx Biosciences, Inc. INBX|I-Mab Biopharma Co., Ltd. - Wutah bathi saben saham ing taun lumaku|FENC - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Heron Therapeutics|NVCT: Wutah bathi ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku Coherus BioSciences CHRS|Wutah bathi resik saben saham ing taun iki CRBP|Kacepetan wutah bathi saben saham ing taun lumaku Cardiff Oncology Corp CRDF|Wutah bathi resik saben saham ing taun iki BYSI (BeyondSpring Pharma)|BCAB (bioatla.com) - Tambahing bathi saben saham ing taun lumaku|Lixte Biotechnology - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku CTXR (Citius Pharmaceuticals Inc.)|BioLineRx - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku CANF (Can-Fite BioPharma Ltd)|APRE: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Kazia Therapeutics Limited (KZIA)|Wutah bathi saben saham ing taun lumaku Silexion Therapeutics Corp.|NCNA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku CMRX|Wutah bathi ing taun lumaku Cyclacel Pharmaceuticals, Inc. (CYCC)|Wutah bathi saben saham ing taun lumaku G1 Therapeutics GTHX|KRON (Kronos Bio Corporation) - Dinamika bathi saben saham ing taun lumaku|KTRA: Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku oncternal.com|PRTG: Wutah bathi ing taun lumaku